Aegerion Pharmaceuticals Observes Rare Disease Day 2012
February 29, 2012 08:00 ET
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Feb. 29, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...
Aegerion Pharmaceuticals Announces Lomitapide 78-Week Phase III Clinical Data Consistent With Earlier Results
January 06, 2012 12:57 ET
|
Aegerion Pharmaceuticals, Inc.
Efficacy and Safety Profile Maintained
Company to Webcast Presentation at the 30th Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Jan. 6, 2012 (GLOBE NEWSWIRE) -- Aegerion...
Sandford D. Smith Appointed to Aegerion Pharmaceuticals' Board of Directors
December 20, 2011 08:00 ET
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Dec. 20, 2011 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...